Latest Cataplexy Stories
Trial Initiated in Response to a FDA Pediatric Written Request to Study Xyrem in Children and Adolescents DUBLIN, Dec.
$30,000 Grant to Dr. Thomas Scammell Supports Ongoing Search for Narcolepsy Cure WORCESTER, Mass., Dec. 1, 2014 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy, Inc.
WORCESTER, Mass., Nov.
Accomplished trio join a Board managing the challenges and opportunities of growth WORCESTER, Mass., Sept.
Nonprofit Continues Support in the Search for Narcolepsy Cure WORCESTER, Mass., July 3, 2014 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy, Inc.
Study Demonstrated Robust Alerting Effect Consistent with Phase 2a Results DUBLIN, June 2, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented data from the Phase 2b
Phase 2b Data for JZP-110 in Adults with EDS in Narcolepsy Accepted as Late-Breaker Oral Presentation DUBLIN, May 27, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced
Normally muscles contract in order to support the body, but in a rare condition known as cataplexy the body's muscles "fall asleep" and become involuntarily paralyzed.